Pharmaceutical compositions and methods of treatment based...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/11 (2006.01) A61K 48/00 (2006.01) G01N 33/50 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2397919

This invention relates to compositions and methods for inhibition of abnormal proliferation of cells or angiogenesis. More particularly this invention provides VEGF antisense oligonucleotides capable of inhibiting proliferation of cancer cells or angiogenesis or combinations thereof. Also provided are screening and prognostic assays, as well kits comprising the VEGF antisense oligonucleotides.

La présente invention concerne des compositions et des méthodes destinées à inhiber la prolifération anormale de cellules ou l'angiogenèse. La présente invention concerne, en particulier, des oligonucléotides antisens, dirigés contre le facteur de croissance de l'endothélium vasculaire (VEGF), qui sont capables d'inhiber la prolifération des cellules cancéreuses, l'angiogenèse ou des combinaisons de ces phénomènes. L'invention concerne également des analyses de détection et de pronostic, ainsi que des kits comprenant lesdits oligonucléotides antisens dirigés contre le VEGF.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical compositions and methods of treatment based... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions and methods of treatment based..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions and methods of treatment based... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1728158

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.